Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade C 15.22 1.94% 0.29
QURE closed up 1.94 percent on Wednesday, November 22, 2017, on 47 percent of normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical QURE trend table...

Date Alert Name Type % Chg
Nov 22 Bollinger Band Squeeze Range Contraction 0.00%
Nov 21 Bollinger Band Squeeze Range Contraction 1.94%
Nov 17 NR7 Range Contraction 1.20%
Nov 17 Narrow Range Bar Range Contraction 1.20%
Nov 15 Hammer Candlestick Bullish 2.98%
Nov 15 1,2,3 Pullback Bullish Bullish Swing Setup 2.98%
Nov 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.98%
Nov 14 1,2,3 Pullback Bullish Bullish Swing Setup -2.12%
Nov 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.12%
Nov 13 1,2,3 Pullback Bullish Bullish Swing Setup -0.91%

Older signals for QURE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Is QURE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.35
52 Week Low 4.72
Average Volume 889,039
200-Day Moving Average 8.0188
50-Day Moving Average 12.8168
20-Day Moving Average 15.35
10-Day Moving Average 15.26
Average True Range 1.1421
ADX 32.96
+DI 26.77
-DI 18.39
Chandelier Exit (Long, 3 ATRs ) 16.0637
Chandelier Exit (Short, 3 ATRs ) 17.1363
Upper Bollinger Band 16.3321
Lower Bollinger Band 14.3679
Percent B (%b) 0.43
BandWidth 12.796091
MACD Line 0.5185
MACD Signal Line 0.8004
MACD Histogram -0.2819
Fundamentals Value
Market Cap 389.02 Million
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -5.40
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.51
Resistance 3 (R3) 16.47 16.01 16.30
Resistance 2 (R2) 16.01 15.68 16.03 16.22
Resistance 1 (R1) 15.61 15.48 15.81 15.65 16.15
Pivot Point 15.15 15.15 15.25 15.17 15.15
Support 1 (S1) 14.75 14.82 14.95 14.79 14.29
Support 2 (S2) 14.29 14.62 14.31 14.22
Support 3 (S3) 13.89 14.29 14.15
Support 4 (S4) 13.93